Odds of clinical malaria or asymptomatic infection amongst sero-positive individuals, by antigen | ||||||
---|---|---|---|---|---|---|
 | Unadjusted | Adjusted | ||||
OR | 95% CI | p value | aOR | 95% CI | p value | |
Etramp5.Ag1 | ||||||
 Clinical malaria | 5.88 | 3.44–10.03 | < 0.001 | 4.60 | 2.98–7.12 | < 0.001 |
 Asymptomatic infection | 3.20 | 2.64–3.88 | < 0.001 | 3.33 | 2.72–4.08 | < 0.001 |
GEXP18 | ||||||
 Clinical malaria | 2.57 | 1.44–4.61 | 0.002 | 1.48 | 0.90–2.41 | 0.122 |
 Asymptomatic infection | 2.94 | 2.38–3.64 | < 0.001 | 3.12 | 2.50–3.90 | < 0.001 |
HSP40.Ag1 | ||||||
 Clinical malaria | 1.67 | 0.88–3.18 | 0.119 | 0.99 | 0.59–1.65 | 0.956 |
 Asymptomatic infection | 2.53 | 2.06–3.10 | < 0.001 | 2.64 | 2.09–3.33 | < 0.001 |
Rh2.2030 | ||||||
 Clinical malaria | 2.20 | 1.10–4.38 | 0.025 | 1.28 | 0.77–2.12 | 0.338 |
 Asymptomatic infection | 2.45 | 1.98–3.03 | < 0.001 | 3.06 | 2.40–3.89 | < 0.001 |
EBA175 | ||||||
 Clinical malaria | 1.37 | 0.67–2.81 | 0.390 | 1.54 | 0.86–2.75 | 0.147 |
 Asymptomatic infection | 2.09 | 1.74–2.51 | < 0.001 | 2.86 | 2.21–3.72 | < 0.001 |
PfMSP119 | ||||||
 Clinical malaria | 3.83 | 1.95–7.51 | < 0.001 | 4.09 | 2.60–6.44 | < 0.001 |
 Asymptomatic infection | 2.29 | 1.82–2.88 | < 0.001 | 2.49 | 1.90–3.27 | < 0.001 |
PfAMA1 | ||||||
 Clinical malaria | 2.21 | 1.25–3.90 | 0.006 | 2.32 | 1.40–3.85 | 0.001 |
 Asymptomatic infection | 2.62 | 2.12–3.24 | < 0.001 | 3.80 | 2.95–4.90 | < 0.001 |
PfGLURP.R2 | ||||||
 Clinical malaria | 2.17 | 1.28–3.68 | 0.004 | 3.12 | 2.12–4.59 | < 0.001 |
 Asymptomatic infection | 2.38 | 1.96–2.89 | < 0.001 | 3.80 | 2.92–4.95 | < 0.001 |